Weekly outline

    《尊重智慧財產權，請使用正版教科書，勿非法影印書籍及教材，以免侵犯他人著作權》

    【瀏覽課程大綱Syllabus】【列印Print】

  • General

  • 1. 9 September - 15 September

    The power of bacteria

    • On-demand biomanufacturing of protective conjugate vaccines

    • 2. 16 September - 22 September

      Skin and Mucosa: the First Lines of Defense against Bacterial Infections

      • On-demand biomanufacturing of protective conjugate vaccines

      • 3. 23 September - 29 September

        The Innate Immune System: Always on Guard

        • Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines

        • 4. 30 September - 6 October

          The Second Line of Defense: Antibodies and Cytotoxic T Cells

          • Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines

          • 5. 7 October - 13 October

            The Norma Microbiota

            • Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates.

            • 6. 14 October - 20 October

              Microbes and Disease: Establishing a Connection

              • Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates

              • 7. 21 October - 27 October

                Mechanisms of Genetic Modification and Exchange: Role in Pathogen Evolution

                • Development of an automated platform for the optimal production of glycoconjugatevaccines expressed in Escherichia coli

                • 8. 28 October - 3 November

                  Review

                  • Development of an automated platform for the optimal production of glycoconjugatevaccines expressed in Escherichia coli

                  • 9. 4 November - 10 November

                    Midterm examination

                    • Uncoupling of invasive bacterial mucosal immunogenicity from pathogenicity

                    • 10. 11 November - 17 November

                      Identification of Virulence Factors: Measuring Infectivity and Virulence

                      • Uncoupling of invasive bacterial mucosal immunogenicity from pathogenicity

                      • 11. 18 November - 24 November

                        Identification of Virulence Factors: Molecular Approaches for Bacterial Factors

                        • Improving cell-free glycoprotein synthesis by characterizing and enriching native membrane vesicles

                        • 12. 25 November - 1 December

                          Identification of Virulence Factors: Molecular Approaches for Host Factors

                          • Improving cell-free glycoprotein synthesis by characterizing and enriching native membrane vesicles

                          • 13. 2 December - 8 December

                            Toxins and Other Toxic Virulence Factors

                            • Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

                            • 14. 9 December - 15 December

                              Delivery of Virulence Factors

                              • Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

                              • 15. 16 December - 22 December

                                Antimicrobial Compounds

                                • Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria

                                • 16. 23 December - 29 December

                                  How Bacteria Become Resistant to Antibiotics

                                  • Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria

                                  • 17. 30 December - 5 January

                                    Vaccination—anUnderappreciated Component of the Modern Medical Armamentarium

                                    • The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination

                                    • 18. 6 January - 12 January

                                      Final examination

                                      • Exploration of Recombinant Fusion Proteins YAPO and YAPL as Carrier Proteins for Glycoconjugate Vaccine Design again stStreptococcus pneumoniae Infection